MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097881 A) filed by Marinomed Biotech Ag, Korneuburg, Austria, on Oct. 10, for 'spraying device comprising aqueous budesonide composition.'
Inventor(s) include Prieschl-Grassauer, Eva; Roch-Nakowitsch, Sabine; Gossl, Andreas; and Sladek, Svenja.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "Disclosed is a spraying device for nasal or buccal delivery of a buffered aqueous composition comprising solubilized budesonide, which has improved long-term storage stability and reduced amounts of impurities, the buffer adjusted to pH 4 to 5, wherein budesonide is dissolved at a concentration of at least 100 /vg/mL, wherein the composition is free of metal ions and packed into a metal-free first containment closed with a spray pump system packaged into a sealed oxygen-impermeable, oxygen-free second containment, and wherein the composition after storage at 25 C over a period of 1 2 months contains at least 90%, preferably at least 95 %, of the nominal starting concentration of solubilized budesonide, and no more than 1 %, relative to the budesonide concentration, of total impurities. The invention further relates to the composition for use as a medicament in the treatment of inflammatory diseases or conditions."
The patent application was internationally filed on Mar. 12, 2024, under International application No.PCT/EP2024/056592.
Disclaimer: Curated by HT Syndication.
